Breakthrough genomic cancer testing from a single blood draw
What is Guardant360?
A simple blood draw is all it takes
Our 73-gene panel targets actionable somatic alterations
Used by all 27 National Comprehensive Cancer Network Centers
Treatment must too
Access precision care through a simple blood test
The precise genomic picture without the risks
See how non-invasive, comprehensive
tumor-DNA testing helped Susan and Carole
Trusted by leading oncologists at top cancer centers
See how doctors use Guardant360
to help patients
Guardant360 is comprehensive and accurate
The most validated comprehensive liquid biopsy
Guardant Health has been used over 70,000 times by more than 5,000 oncologists and at all 27 National Comprehensive Network Cancer Centers. Our clinical research collaborations have resulted in over 70 peer-reviewed publications.
The vast majority of NCI comprehensive cancer centers use our test, along with a growing number of research and community oncologists.